Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy
| Autor: | Kazuo Tamura, Olga Ab, Kenji Ishitsuka, Victor S. Goldmacher, Shiro Jimi |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Cell Survival
medicine.medical_treatment Antineoplastic Agents Maytansinoid Malignancy Ado-Trastuzumab Emtansine Antibodies Monoclonal Humanized Targeted therapy chemistry.chemical_compound medicine Tumor Cells Cultured Humans Maytansine Modality (human–computer interaction) Dose-Response Relationship Drug business.industry HuN901-DM1 Antibodies Monoclonal Hematology Trastuzumab Natural killer T cell medicine.disease CD56 Antigen Immunoconjugate Lymphoma Extranodal NK-T-Cell chemistry Immunology Cancer research business Cell Division |
| Zdroj: | British journal of haematology. 141(1) |
| ISSN: | 1365-2141 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text